Todd Bourcier

3.0k total citations · 1 hit paper
19 papers, 2.4k citations indexed

About

Todd Bourcier is a scholar working on Immunology, Cancer Research and Molecular Biology. According to data from OpenAlex, Todd Bourcier has authored 19 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 7 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Todd Bourcier's work include NF-κB Signaling Pathways (4 papers), Immunotoxicology and immune responses (3 papers) and Carcinogens and Genotoxicity Assessment (3 papers). Todd Bourcier is often cited by papers focused on NF-κB Signaling Pathways (4 papers), Immunotoxicology and immune responses (3 papers) and Carcinogens and Genotoxicity Assessment (3 papers). Todd Bourcier collaborates with scholars based in United States, Switzerland and Italy. Todd Bourcier's co-authors include Peter Libby, Galina K. Sukhova, Amir Kol, Andrew H. Lichtman, Uwe Schönbeck, François Mach, Jean‐Yves Bonnefoy, Jordan S. Pober, Stefan Frantz and Ralph A. Kelly and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Todd Bourcier

18 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40–CD40 ligand signaling in atherosclerosis

1997 588 citations François Mach, Uwe Schönbeck et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Todd Bourcier United States	12	1.1k	837	349	332	282	19	2.4k
Erik Michaëlsson Sweden	30	1.3k 1.2×	852 1.0×	283 0.8×	142 0.4×	287 1.0×	55	2.9k
Gernot Schabbauer Austria	34	1.3k 1.2×	1.5k 1.8×	409 1.2×	402 1.2×	235 0.8×	76	3.5k
Levente József Canada	24	947 0.9×	861 1.0×	510 1.5×	161 0.5×	263 0.9×	32	2.3k
C Kunsch United States	10	838 0.8×	665 0.8×	204 0.6×	408 1.2×	152 0.5×	17	2.0k
Markku O. Pentikäinen Finland	30	1.0k 1.0×	841 1.0×	523 1.5×	348 1.0×	821 2.9×	62	2.9k
Kazutaka Hayashida Japan	27	1.6k 1.5×	624 0.7×	313 0.9×	207 0.6×	295 1.0×	44	2.7k
Xuebin Qin United States	33	1.4k 1.2×	1.1k 1.3×	413 1.2×	129 0.4×	273 1.0×	93	3.6k
Xiang‐An Li United States	27	583 0.5×	895 1.1×	448 1.3×	286 0.9×	584 2.1×	57	2.5k
Bruce D. Car United States	26	1.4k 1.2×	886 1.1×	279 0.8×	433 1.3×	345 1.2×	56	3.9k
Xiaorong Zhou China	27	597 0.5×	976 1.2×	165 0.5×	272 0.8×	214 0.8×	120	2.2k

Countries citing papers authored by Todd Bourcier

Since Specialization

Citations

This map shows the geographic impact of Todd Bourcier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd Bourcier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd Bourcier more than expected).

Fields of papers citing papers by Todd Bourcier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd Bourcier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd Bourcier. The network helps show where Todd Bourcier may publish in the future.

Co-authorship network of co-authors of Todd Bourcier

This figure shows the co-authorship network connecting the top 25 collaborators of Todd Bourcier. A scholar is included among the top collaborators of Todd Bourcier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd Bourcier. Todd Bourcier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Simpson, Natalie E., Todd Bourcier, & Nakissa Sadrieh. (2025). A Food and Drug Administration/Center for Drug Evaluation and Research nonclinical perspective on the use of human-induced pluripotent stem cell-derived cardiomyocyte data for cardiovascular safety assessment and regulatory decisions. Toxicological Sciences. 206(2). 219–227. 1 indexed citations

Faske, Jennifer, et al.. (2024). CarcSeq detection of lorcaserin-induced clonal expansion ofPik3caH1047R mutants in rat mammary tissue. Toxicological Sciences. 201(1). 129–144. 3 indexed citations

Bourcier, Todd, Timothy J. McGovern, Akiyoshi Nishikawa, et al.. (2024). ICH S1 prospective evaluation study: weight of evidence approach to predict outcome and value of 2-year rat carcinogenicity studies. A report from the regulatory authorities subgroup. SHILAP Revista de lepidopterología. 6. 1353783–1353783. 8 indexed citations

Ackley, David H., Todd Bourcier, Andrew L. Goodwin, et al.. (2022). FDA and industry collaboration: Identifying opportunities to further reduce reliance on nonhuman primates for nonclinical safety evaluations. Regulatory Toxicology and Pharmacology. 138. 105327–105327. 22 indexed citations

Bonzo, Jessica A., Todd Bourcier, Ikram Elayan, et al.. (2020). An FDA/CDER perspective on nonclinical testing strategies: Classical toxicology approaches and new approach methodologies (NAMs). Regulatory Toxicology and Pharmacology. 114. 104662–104662. 112 indexed citations

Bourcier, Todd, et al.. (2015). Improving prediction of carcinogenicity to reduce, refine, and replace the use of experimental animals.. PubMed. 54(2). 163–9. 25 indexed citations

Blind, E., Kristina Dunder, Pieter A. de Graeff, et al.. (2014). Pancreatic Safety of Incretin-Based Drugs — FDA and EMA. 8 indexed citations

Morton, Daniel, Todd Bourcier, & Carl L. Alden. (2012). Improving Carcinogenicity Assessment. Toxicologic Pathology. 41(2). 263–270. 6 indexed citations

Massaro, Marika, Aı̈da Habib, Serena Del Turco, et al.. (2006). The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKCε inhibition. Proceedings of the National Academy of Sciences. 103(41). 15184–15189. 177 indexed citations

10.

Walsh, Mary C., Todd Bourcier, Kazue Takahashi, et al.. (2005). Mannose-Binding Lectin Is a Regulator of Inflammation That Accompanies Myocardial Ischemia and Reperfusion Injury. The Journal of Immunology. 175(1). 541–546. 198 indexed citations

11.

Bourcier, Todd. (2003). Electromobility Shift Analysis (EMSA) Applied to the Study of NF-kappa B Binding Interactions in Vascular Smooth Muscle Cells. Humana Press eBooks. 30. 159–168.

12.

Oyama, Jun‐ichi, Stefan Frantz, Charles Blais, Ralph A. Kelly, & Todd Bourcier. (2002). Nitric Oxide, Cell Death, and Heart Failure. Heart Failure Reviews. 7(4). 327–334. 8 indexed citations

13.

Frantz, Stefan, Ralph A. Kelly, & Todd Bourcier. (2001). Role of TLR-2 in the Activation of Nuclear Factor κB by Oxidative Stress in Cardiac Myocytes. Journal of Biological Chemistry. 276(7). 5197–5203. 227 indexed citations

14.

Caterina, Raffaele De, Todd Bourcier, Ulrich Laufs, et al.. (2001). Induction of Endothelial-Leukocyte Interaction by Interferon-γ Requires Coactivation of Nuclear Factor-κB. Arteriosclerosis Thrombosis and Vascular Biology. 21(2). 227–232. 24 indexed citations

15.

Kol, Amir, Todd Bourcier, Andrew H. Lichtman, & Peter Libby. (1999). Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. Journal of Clinical Investigation. 103(4). 571–577. 419 indexed citations

16.

Marx, Nikolaus, Todd Bourcier, Galina K. Sukhova, Peter Libby, & Jorge Plutzky. (1999). PPARγ Activation in Human Endothelial Cells Increases Plasminogen Activator Inhibitor Type-1 Expression. Arteriosclerosis Thrombosis and Vascular Biology. 19(3). 546–551. 323 indexed citations

17.

Bourcier, Todd, Galina K. Sukhova, & Peter Libby. (1997). The Nuclear Factor κ-B Signaling Pathway Participates in Dysregulation of Vascular Smooth Muscle Cells in Vitroand in Human Atherosclerosis. Journal of Biological Chemistry. 272(25). 15817–15824. 223 indexed citations

18.

Mach, François, Uwe Schönbeck, Galina K. Sukhova, et al.. (1997). Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40–CD40 ligand signaling in atherosclerosis. Proceedings of the National Academy of Sciences. 94(5). 1931–1936. 588 indexed citations breakdown →

19.

Bourcier, Todd, Michael E. Dockter, & Aviv Hassid. (1995). Synergistic interaction of interleukin‐1β and growth factors in primary cultures of rat aortic smooth muscle cells. Journal of Cellular Physiology. 164(3). 644–657. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact